Human VWF(Von Willebrand Factor) ELISA Kit
中文名称：人血管性血友病因子(VWF)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 1.56-100 ng/mL
- 灵敏度： 0.94 ng/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人VWF抗体包被于酶标板上，实验时样品（或标准品）中的人VWF会与包被抗体结合。后依次加入生物素化的抗人VWF抗体和辣根过氧化物酶标记的亲和素，抗人VWF抗体与结合在包被抗体上的人VWF结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，VWF浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中VWF的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 1.56-100 ng/mL |
| 灵敏度 | 0.94 ng/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人VWF，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
EFFECT OF HEMODIALYSIS WITH MEDIUM CUT-OFF vs. HIGH-FLUX MEMBRANES ON ENDOTHELIAL FUNCTION OF PATIENTS WITH CHRONIC KIDNEY DISEASE
IF: 3.000 -
Early Use of PCSK9 Inhibitors in the Prognosis of Patients with Acute Coronary Syndrome by Protecting Vascular Endothelial Function
IF: 2.900 -
Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
IF: 2.700Journal： International Journal of Chronic Obstructive Pulmonary Disease (2024)Reactivity：HumanSample Type：Plasma -
Physiological, biochemical and genome-wide expression patterns during graded normobaric hypoxia in healthy individuals
IF: 2.500Journal： PHYSIOLOGICAL GENOMICS (2024)Reactivity：HumanSample Type：serum -
Adhatoda vasica and Tinospora cordifolia extracts ameliorate clinical and molecular markers in mild COVID-19 patients: a randomized open-label three-armed study
IF: 4.200Journal： EUROPEAN JOURNAL OF MEDICAL RESEARCH (2023)PMID：38049897Reactivity：HumanSample Type：serum -
High mobility group box 1 derived mainly from platelet microparticles exacerbates microvascular obstruction in no reflow
IF: 10.407 -
Association of Heparin-Like Effect, Factor VII/XIII Deficiency and?Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding
IF: 3.487 -
Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
IF: 6.313 -
Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling pathway
IF: 3.932 -
Prognostic Significance of Plasma Hepatocyte Growth Factor in Sepsis
IF: 3.510Journal： JOURNAL OF INTENSIVE CARE MEDICINE (2021)PMID：33611982Reactivity：HumanSample Type：Plasma
实验操作视频
